A number of other firms have also recently commented on LHCG. Analysts at Deutsche Bank (NYSE: DB) upgraded shares of LHC Group from a “hold” rating to a “buy” rating in a research note to investors on Thursday, March 1st. Analysts at Piper Jaffray (NYSE: PJC) raised their price target on shares of LHC Group from $15.00 to $20.00 in a research note to investors on Wednesday, February 15th. They now have an “overweight” rating on the stock.
LHC Group traded down 2.97% on Thursday, hitting $18.31. LHC Group has a 1-year low of $12.34 and a 1-year high of $29.04. The company’s market cap is $337.1 million.
The company last announced its quarterly results on Wednesday, May 2nd. It reported $0.44 earnings per share (EPS) for the previous quarter, beating the Thomson Reuters consensus estimate of $0.36 EPS by $0.08. The company’s quarterly revenue was down 1.9% on a year-over-year basis. Analysts expect that LHC Group will post $0.39 EPS next quarter.
LHC Group, Inc. (LHC Group) provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals (LTACHs).